Zhejiang Cheng Yi Pharmaceutical Co., Ltd.

¥6.73As of Sun 8 Nov 2026, 12:00 UTC
SSE:603811Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (2.95%)
Div yield 3.18%
ROE 13.50%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.22
PE TTM 16.25
TSR TTM (18.66%)
Mkt cap ¥2.993B
ROIC 11.23%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥6.53
(2.94%)
(0.58%)
Hold 2|8|11|10|2
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.13
0.13
0.14
0.15
30.46%
21.31%
17.67%
20.75%
Revenue¥M
302.7
297.0
301.0
305.5
11.88%
4.73%
2.44%
6.65%
Peers (US$448.7M)
Cap (US$)
PE
436.6M
—
450.4M
—
Capital
TTM
5Y
10Y
Leveragex
2.080
(0.034)
(0.023)
EBIT/Intx
2.011
0.193
0.144
Own earn%
(103.48)
(7.41)
(9.93)
Sh yield%
33.55
31.13
25.30
Owners
Insiders/Inst%
11.35
56.96
Short interest%
5.56
SBC / revenue%
5.24
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
17–23
$1 testx
0.0
Incr. ROIC%
4